BURRELL INTERNATIONAL GROUP LLC

Lobbying for SHIONOGI INC. · Pharmaceutical Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $40,000.00 income · posted Jul 19, 2026

Lobbying activity 1

Pharmacy

FY27 Appropriations and policy for the Strategic National Stockpile, BARDA, and Industrial Base Management Supply Chain, Pandemic and All Hazards Preparedness Act (PAHPA), PASTEUR Act and MCM Development funding; AMR issues; PBS/SRF, and PRV and MCM voucher programs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.